Skip to main content

Advertisement

Table 1 Clinico-pathological characteristics of breast cancer samples

From: miRNome of inflammatory breast cancer

  Breast carcinomas p-valuea,b
nonIBC IBC
Characteristics (nb,%) (n = 17) (n = 13)
Age    
Mean ± SD 57.4 ± 12.4 54.4 ± 13.4 0.27a
≤50 5 (29%) 5 (38%) 0.71b
>50 12 (71%) 8 (62%)
Stage    
I 4 (24%) 0 (0%) <0.001b
II 1 (6%) 0 (0%)
IIA 8 (47%) 0 (0%)
IIB 1 (6%) 1 (8%)
III 0 (0%) 1 (8%)
IIIA 2 (12%) 0 (0%)
IIIB 0 (0%) 9 (69%)
IIIC 1 (6%) 1 (8%)
IV 0 (0%) 1 (8%)
Distant metastates    
Yes 0 (0%) 2 (15%) 0.18b
No 17 (100%) 11 (85%)  
Estrogen receptor status    
Positive 12 (71%) 5 (38%) 0.14b
Negative 5 (29%) 8 (62%)
Progesterone receptor status    
Positive 9 (53%) 2 (15%) 0.06b
Negative 8 (47%) 11 (85%)
HER2 status    
Positive 4 (24%) 2 (15%) 0.67b
Negative 13 (76%) 11 (85%)
Molecular subtypes    
HR-HER2- 3 (18%) 7 (54%) 0.19b
HR-HER2+ 1 (6%) 1 (8%)
HR+HER2- 10 (59%) 4 (31%)
HR+HER2+ 3 (18%) 1 (8%)
  1. aStudent’t test, bFisher’s exact test.
  2. HR: Hormone Receptor; HR-: ER and PR negative; HR+: ER and/or PR positive.